Radiotherapy & Oncology
Volume 95, Issue 2 , Pages 198-202 , May 2010

Rectal dose variation during the course of image-guided radiation therapy of prostate cancer

Received 5 June 2009 ,Revised 19 February 2010 ,Accepted 23 February 2010.

References 

  1. Schulze D, Liang J, Yan D, et al. Comparison of various online IGRT strategies: the benefits of online treatment plan re-optimization. Radiother Oncol. 2009;90:367–376
  2. Nichol AM, Brock KK, Lockwood GA, et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys. 2007;67:48–56
  3. Lilleby W, Fosså SD, Knutsen BH, et al. Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation. Radiother Oncol. 2000;57:195–200
  4. Melancon AD, O’Daniel JC, Zhang L, et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?. Radiother Oncol. 2007;85:251–259
  5. Hector CL, Webb S, Evans PM. The dosimetric consequences of inter-fractional patient movement on conventional and intensity-modulated breast radiotherapy treatments. Radiother Oncol. 2000;54:57–64
  6. Wu QJ, Thongphiew D, Wang Z, et al. On-line re-optimization of prostate IMRT plans for adaptive radiation therapy. Phys Med Biol. 2008;53:673–691
  7. Ma C-M, Paskalev K. In-room CT techniques for image-guided radiation therapy. Med Dosim. 2006;31:30–39
  8. Li JS, Jin L, Pollack A, et al. Gains from real-time tracking of prostate motion during external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2009;75:1613–1620
  9. Kupelian PA, Langen KM, Zeidan OA, et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:876–882
  10. Pollack A, Hanlon AL, Horwitz EM, et al. Radiation therapy dose escalation for prostate cancer: a rational for IMRT. World J Urol. 2003;21:200–208
  11. Pollack A, Price R, Dong L, et al. Intact prostate cancer: overview. In:  Mundt AJ,  Roeske JC editor. Intensity modulated radiation therapy: a clinical perspective. Ontario, Canada: BC Decker; 2005;p. 459–469
  12. Pollack A, Hanlon AL, Horwitz EM, et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys. 2006;64:518–526
  13. Pollack A, Price RA. IMRT for prostate cancer. In: Palta JR, Mackie TR, editors. Intensity modulated radiation therapy: the state of the art. AAPM monograph no. 29. Madison WI: Medical Physics Publishing; 2003. p. 617–630.
  14. Paskalev K, Ma C-M, Jacob R, et al. Daily target localization for prostate patients based on 3D image correlation. Phys Med Biol. 2004;49:931–939
  15. Landoni V, Saracino B, Marzi S, et al. A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. Int J Radiat Oncol Biol Phys. 2006;65:587–594
  16. Lam KL, Ten Haken RK, Lintzberg D, et al. An application of Bayesian statistical methods to adaptive radiotherapy. Phys Med Biol. 2005;50:3849–3858
  17. Rehbinder H, Forsgren C, Löf J. Adaptive radiation therapy for compensation of errors in patient set up and treatment delivery. Med Phys. 2004;31:3363–3371
  18. Kupelian P, Kuban D, et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys. 2005;61:415–419
  19. Pollack A, Hanlon AL, Horwitz EM, et al. Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol. 2004;171:1132–1136
  20. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001;166:876–881
  21. Pollack A, Zagars GK, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097–1105
  22. Leibel SA, Fuks Z, et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol. 2003;30:596–615
  23. Schultheiss TE, Lee WR, Hunt MA, et al. Late GI, and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:3–11
  24. Paskalev K, Feigenberg S, Jacob R, et al. Target localization for post-prostatectomy patients using CT and ultrasound image guidance. J Appl Clin Med Phys. 2005;4:40–49
  25. Pollack A, Hanlon AL, Horwitz EM, et al. A study of dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys. 2006;64:518–526

PII: S0167-8140(10)00128-3

doi: 10.1016/j.radonc.2010.02.023

Radiotherapy & Oncology
Volume 95, Issue 2 , Pages 198-202 , May 2010

Article Tools

* Image Usage & Resolution